Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Consistent with the prescribing information for these medications, health care professionals should monitor for and advise patients using GLP-1 RAs to report new or worsening depression, suicidal thoughts, or any unusual changes in mood or behavior
For example, our pipeline and drug surveillance teams continuously monitor new drug launches, formulations and indications of GLP-1s
GLP-1s are not for everyone
Outcomes Compared with the SGLT2 inhibitors group, there was no evidence that the GLP-1RAs group was associated with the following outcomes: (1) the new onset of heart failure (HR 0.97
US$ 20.87
US$ 28.22
US$ 21.97
